Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Investigating inflammation in cardiometabolic health

Official title: Inflammatory Resolution in Cardiometabolic Health and Disease - an Aarhus Based Cohort

Run by University of Aarhus · NCT06390189 · Data updated 2026-11-12

This study is trying to see how inflammation affects people’s heart and metabolic health by comparing blood samples from lean, overweight, and obese volunteers.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment240 (estimated)
SponsorUniversity of Aarhus
Academic / other
Drugs / interventionsmethotrexate
Locations1 site (Aarhus)
StatusRecruiting
StartedMay 7, 2024
Main results expectedSeptember 1, 2026
Study endsSeptember 1, 2028
Registry record updatedJune 28, 2024
Trial IDNCT06390189 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with a BMI greater than 18.5 kg/m2, categorized as either metabolically healthy or unhealthy.

Probably not a fit

Patients with chronic inflammation, those on immunosuppressive drugs, or individuals regularly using medications that affect inflammatory resolution may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify molecular pathways that distinguish metabolically healthy individuals from those who are unhealthy, focusing on the role of pro-resolving lipids in inflammation. Volunteers will be recruited based on their BMI, which will categorize them into lean, overweight, or obese groups. The hypothesis is that metabolically healthy individuals possess a better ability to manage inflammatory responses. The study will involve analyzing blood samples to assess inflammatory markers and lipid profiles.

Why it matters

Potential benefit: If successful, this study could lead to new therapeutic strategies for managing inflammation in cardiometabolic diseases.

How similar studies have gone: While the specific approach of this study may be novel, previous studies have shown that understanding inflammation can lead to significant advancements in treating cardiometabolic conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed signed consent has been obtained from the volunteer.
* The volunteer has a BMI greater than 18.5 kg/m2
* Men and women over the age of 18 are included.

Exclusion Criteria:

* The study staff contacting a potential participant perceives that the individual has difficulty understanding the information.
* An MD determines that the individual is on too many medications to participate.
* The individual takes a medication that is approved by the MD, but he/she is not willing or not able to wait with any potential morning medication until after their fasted blood-draw.
* The individual states that they have increased bleeding tendency or are using anti-coagulant (blood thinning) medication.
* The individual has some form of chronic inflammation.
* The individual regularly uses medication that affects inflammatory resolution (e.g., low-dose aspirin).
* The individual uses immunosuppressive drugs (e.g., methotrexate).
* The individual regularly consumes fish oils (omega 3).
* The individual has significant gastrointestinal problems.
* The individual smokes or uses chewing tobacco.
* The individual has been drinking alcohol two days before the study visit.
* The individual has tattoos or body piercings on the forearms and / or the stomach that can affect the examination.
* The individual does not follow instructions given in the research study.

Where it's running

  • Steno Diabetes Center Aarhus, Aarhus University Hospital
    Aarhus, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.